Implantation of Myogenic Cells in Skeletal Muscles

Principles of Regenerative Medicine

Volumn , Issue , 2008, Pages 782-793

  Skuk, Daniel ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72049119293     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369410-2.50048-6     Document Type: Chapter

References (69)

1. Alameddine H.S., Louboutin J.P., Dehaupas M., Sebille A., Fardeau M. Functional recovery induced by satellite cell grafts in irreversibly injured muscles. Cell Transplant 1994, 3:3-14.
2. Beauchamp J.R., Morgan J.E., Pagel C.N., Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 1999, 144:1113-1122.
3. Betz E.H., Firket H., Reznik M. Some aspects of muscle regeneration. Int. Rev. Cytol. 1966, 19:203-227.
4. Borisov A.B. Regeneration of skeletal and cardiac muscle in mammals: do nonprimate models resemble human pathology?. Wound Repair. Regen. 1999, 7:26-35.
5. Brimah K., Ehrhardt J., Mouly V., Butler-Browne G.S., Partridge T.A., Morgan J.E. Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum. Gene Ther. 2004, 15:1109-1124.
6. Camirand G., Caron N.J., Turgeon N.A., Rossini A.A., Tremblay J.P. Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation. Transplantation 2002, 73:453-461.
7. Camirand G., Rousseau J., Ducharme M.E., Rothstein D.M., Tremblay J.P. Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism. Am. J. Transplant. 2004, 4:1255-1265.
8. Cantini M., Massimino M.L., Catani C., Rizzuto R., Brini M., Carraro U. Gene transfer into satellite cell from regenerating muscle: bupivacaine allows beta-Gal transfection and expression in vitro and in vivo. In Vitro Cell Dev. Biol. Anim. 1994, 30A:131-133.
9. Caron N.J., Asselin I., Morel G., Tremblay J.P. Increased myogenic potential and fusion of matrilysinexpressing myoblasts transplanted in mice. Cell Transplant. 1999, 8:465-476.
10. Cousins J.C., Woodward K.J., Gross J.G., Partridge T.A., Morgan J.E. Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal. J. Cell Sci. 2004, 117:3259-3269.
11. El Fahime E., Mills P., Lafreniere J.F., Torrente Y., Tremblay J.P. The urokinase plasminogen activator: an interesting way to improve myoblast migration following their transplantation. Exp. Cell Res. 2002, 280:169-178.
12. Floyd Jr.S.S., Clemens P.R., Ontell M.R., Kochanek S., Day C.S., Yang J., Hauschka S.D., Balkir L., Morgan J., Moreland M.S. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther. 1998, 5:19-30.
13. Gross J.G., Morgan J.E. Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve 1999, 22:174-185.
14. Guerette B., Asselin I., Vilquin J.T., Roy R., Tremblay J.P. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve. 1995, 18:39-51.
15. Guerette B., Roy R., Tremblay M., Asselin I., Kinoshita I., Puymirat J., Tremblay J.P. Increased granzyme B mRNA after alloincompatible myoblast transplantation. Transplantation 1995, 60:1011-1016.
16. Guerette B., Tremblay G., Vilquin J.T., Asselin I., Gingras M., Roy R., Tremblay J.P. Increased interferongamma mRNA expression following alloincompatible myoblast transplantation is inhibited by FK506. Muscle Nerve 1996, 19:829-835.
17. Guerette B., Skuk D., Celestin F., Huard C., Tardif F., Asselin I., Roy B., Goulet M., Roy R., Entman M. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 1997, 159:2522-2531.
18. Gussoni E., Blau H.M., Kunkel L.M. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 1997, 3:970-977.
19. Hall Z.W., Ralston E. Nuclear domains in muscle cells. Cell 1989, 59:771-772.
20. Heslop L., Beauchamp J.R., Tajbakhsh S., Buckingham M.E., Partridge T.A., Zammit P.S. Transplanted primary neonatal myoblasts can give rise to functional satellite cells as identified using the Myf5(nlacZl+) mouse. Gene Ther. 2001, 8:778-783.
21. Huard J., Bouchard J.P., Roy R., Malouin F., Dansereau G., Labrecque C., Albert N., Richards C.L., Lemieux B., Tremblay J.P. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992, 15:550-560.
22. Huard J., Verreault S., Roy R., Tremblay M., Tremblay J.P. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J. Clin. Invest. 1994, 93:586-599.
23. Irintchev A., Zweyer M., Wernig A. Cellular and molecular reactions in mouse muscles after myoblast implantation. J. Neurocytol. 1995, 24:319-331.
24. Irintchev A., Langer M., Zweyer M., Theisen R., Wernig A. Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J. Physiol. (Lond.) 1997, 500:775-785.
25. Irintchev A., Rosenblatt J.D., Cullen M.J., Zweyer M., Wernig A. Ectopic skeletal muscles derived from myoblasts implanted under the skin. J. Cell Sci. 1998, 111:3287-3297.
26. Ito H., Hallauer P.L., Hastings K.E., Tremblay J.P. Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast. Muscle Nerve 1998, 21:291-297.
27. Jones P.H. Implantation of cultured regenerate muscle cells into adult rat muscle. Exp. Neurol. 1979, 66:602-610.
28. Karpati G., Ajdukovic D., Arnold D., Gledhill R.B., Guttman R., Holland P., Koch P.A., Shoubridge E., Spence D., Vanasse M. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 1993, 34:8-17.
29. Kikuchi T., Doerr L., Ashmore C.R. A possible mechanism of phenotypic expression of normal and dystrophic genomes on succinic dehydrogenase activity and fiber size within a single myofiber of m. J. Neurol. Sci. 1980, 45:273-286.
30. Kinoshita I., Vilquin J.T., Guerette B., Asselin I., Roy R., Tremblay J.P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994, 17:1407-1415.
31. Kinoshita I., Vilquin J.T., Gravel C., Roy R., Tremblay J.P. Myoblast allotransplantation in primates. Muscle Nerve 1995, 18:1217-1218.
32. Kinoshita I., Roy R., Dugre F.J., Gravel C., Roy B., Goulet M., Asselin I., Tremblay J.P. Myoblast transplantation in monkeys: control of immune response by FK506. J. Neuropathol. Exp. Neurol. 1996, 55:687-697.
33. Kinoshita I., Vilquin J.T., Tremblay J.P. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice. Acta Neuropathol. 1996, 91:489-493.
34. Kinoshita I., Vilquin J.T., Asselin I., Chamberlain J., Tremblay J.P. Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin-positive membrane. Muscle Nerve 1998, 21:91-103.
35. Konigsberg I.R. The differentiation of cross-striated myofibrils in short term cell culture. Exp. Cell Res. 1960, 21:414-420.
36. Leriche-Guerin K., Anderson L.V., Wrogemann K., Roy B., Goulet M., Tremblay J.P Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscul. Disord. 2002, 12:167-173.
37. Lipton B.H., Schultz E. Developmental fate of skeletal muscle satellite cells. Science 1979, 205:1292-1294.
38. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., Sahenk Z., Benson S., McAndrew P.E., Rice R. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 1995, 333:832-838.
39. Moisset P.A., Skuk D., Asselin I., Goulet M., Roy B., Karpati G., Tremblay J.P. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene. Biochem. Biophys.Res. Commun. 1998, 247:94-99.
40. Morgan J.E., Hoffman E.P., Partridge T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell Biol. 1990, 111:2437-2449.
41. Partridge T.A., Grounds M., Sloper J.C. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature 1978, 273:306-308.
42. Partridge T.A., Morgan J.E., Coulton G.R., Hoffman E.P., Kunkel L.M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989, 337:176-179.
43. Pavlath G.K., Rich K., Webster S.G., Blau H.M. Localization of muscle gene products in nuclear domains. Nature 1989, 337:570-573.
44. Pavlath G.K., Rando T.A., Blau H.M. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J. Cell Biol. 1994, 127:1923-1932.
45. Pin C.L., Merrifield P.A. Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles. Dev. Biol. 1997, 188:147-166.
46. Ralston E., Hall Z.W. Restricted distribution of mRNA produced from a single nucleus in hybrid myotubes. J. Cell Biol. 1992, 119:1063-1068.
47. Sammels L.M., Bosio E., Fragall C.T., Grounds .D., van Rooijen N., Beilharz .W. Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 2004, 77:1790-1797.
48. Satoh A., Labrecque C., Tremblay J.P. Myotubes can be formed within implanted adipose tissue. Transplant. Proc. 1992, 24:3017-3019.
49. Skuk D. Myoblast transplantation for inherited myopathies: a clinical approach. Expert Opin. Biol. Ther. 2004, 4:1871-1885.
50. Skuk D., Tremblay J.P. Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J.Muscle Res. Cell Motil. 2003, 24:285-300.
51. Skuk D., Furling D., Bouchard J.P., Goulet M., Roy B., Lacroix Y., Vilquin J.T., Tremblay J.P., Puymirat J. Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy. J.Neuropathol. Exp. Neurol. 1999, 58:921-931.
52. Skuk D., Roy B., Goulet M., Tremblay J.P. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp. Neurol. 1999, 155:22-30.
53. Skuk D., Goulet M., Roy B., Tremblay J.P. Myoblast transplantation in whole muscle of nonhuman primates. J. Neuropathol. Exp. Neurol. 2000, 59:197-206.
54. Skuk D., Goulet M., Roy B., Tremblay J.P. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp. Neurol. 2002, 175:112-126.
55. Skuk D., Caron N.J., Goulet M., Roy B., Tremblay J.P. Resetting the problem of cell death following musclederived cell transplantation: detection, dynamics and mechanisms. J. Neuropathol. Exp. Neurol. 2003, 62:951-967.
56. Skuk D., Roy B., Goulet M., Chapdelaine P., Bouchard J.P., Roy R., Dugré F.J., Lachance J.G., Deschénes L., Senay H. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol. Ther. 2004, 9:475-482.
57. Skuk, D., Goulet, M., Roy, B., Chapdelaine, P., Bouchard, J.P., Roy, R., Dugré, F.J., Lachance, J.G., Deschênes, L., Senay, H., et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients following high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol. (In press) .
58. Tremblay J.P., Malouin F., Roy R., Huard J., Bouchard J.P., Satoh A., Richards C.L Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 1993, 2:99-112.
59. Vilquin J.T., Asselin I., Guerette B., Kinoshita I., Roy R., Tremblay J.P. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation 1995, 59:422-426.
60. Vilquin J.T., Kinoshita I., Roy B., Goulet M., Engvall E., Tome F., Fardeau M., Tremblay J.P. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. J. Cell Biol. 1996, 133:185-197.
61. Ward .M. Factors predictive of acute renal failure in rhabdomyolysis. Arch. Intern. Med. 1988, 148:1553-1557.
62. Watt D.J., Lambert K., Morgan J.E., Partridge T.A., Sloper J.C. Incorporation of donor muscle precursor cells into an area of muscle regeneration in the host mouse. J. Neurol. Sci. 1982, 57:319-331.
63. Wernig A., Irintchev A. "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells. J. Neurol. Sci. 1995, 130:190-196.
64. Wernig A., Irintchev A., Hartling A., Stephan G., Zimmermann K., Starzinski-Powitz A. Formation of new muscle fibres and tumours after injection of cultured myogenic cells. J. Neurocytol. 1991, 20:982-997.
65. Wernig A., Irintchev A., Lange G. Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression. J. Physiol. (Lond.) 1995, 484:493-504.
66. Wernig A., Zweyer ., Irintchev A. Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J. Physiol. (Lond.) 2000, 522:333-345.
67. Yablonka-Reuveni Z., Nameroff M. Temporal differences in desmin expression between myoblasts from embryonic and adult chicken skeletal muscle. Differentiation 1990, 45:21-28.
68. Yao S.N., Kurachi K. Implanted myoblasts not only fuse with myofibers but also survive as muscle precursor cells. J. Cell Sci. 1993, 105:957-963.
69. Skuk, D., Goulet, M., Roy, B., Chapdelaine, P., Bouchard, J.P., Roy, R., Dugré, F.J., Lachance, J.G., Deschênes, L., Senay, H., et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients following high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol. (In press) .